Boothbay Fund Management, LLC Cara Therapeutics, Inc. Transaction History

Boothbay Fund Management, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$12.38 - $29.19 $761,295 - $1.8 Million	-61,494 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$15.07 - $21.71 $465,150 - $670,100	30,866 Added 100.78%	61,494 $1.34 Million
Q2 2020 Aug 14, 2020	SELL	$12.39 - $17.33 $389,950 - $545,427	-31,473 Reduced 50.68%	30,628 $524,000
Q1 2020 May 15, 2020	BUY	$9.12 - $17.78 $201,561 - $392,955	22,101 Added 55.25%	62,101 $820,000
Q4 2019 Feb 14, 2020	BUY	$16.11 - $25.98 $71,705 - $115,636	4,451 Added 12.52%	40,000 $644,000
Q3 2019 Nov 14, 2019	SELL	$18.28 - $26.91 $656,635 - $966,634	-35,921 Reduced 50.26%	35,549 $650,000
Q2 2019 Aug 14, 2019	BUY	$17.68 - $21.57 $967,767 - $1.18 Million	54,738 Added 327.15%	71,470 $1.54 Million
Q1 2019 May 15, 2019	BUY	$14.41 - $19.64 $241,108 - $328,616	16,732 New	16,732 $328,000
Q3 2018 Nov 14, 2018	SELL	$17.57 - $23.95 $386,540 - $526,900	-22,000 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$11.6 - $19.27 $255,200 - $423,940	22,000 New	22,000 $421,000

12.8M

Ticker CARA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 53,725,900
Market Cap $257M
Description
Cara Therapeutics, Inc., an early commercial-stage biopharmaceutical company, focuses on developing and commercializing chemical entities with a primary focus on pruritus and pain by selectively targeting kappa opioid receptors in the United States. The company is developing product candidates that target the body's peripheral nervous system and...

Get notified when there are updates to the investment portfolio of Boothbay Fund Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Boothbay Fund Management, LLC with notifications on news.